Local isolated reports of coring (Engerix™-B and Infanrix™-IPV+Hib vaccines)

GlaxoSmithKline (GSK) would like to inform healthcare professionals of the isolated reports of stopper coring in Engerix-B and Infanrix-IPV+Hib vaccines. Healthcare professionals are advised to observe the instructions within the products' respective package inserts and to visually inspect for particulate matters before vaccine administration. Please refer to the letter for more information. 

 
 
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under 'For Healthcare Professionals’.

Step 2: Click on 'Restricted Content' and log in via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’.

Step 4: Click on the Drug Alert tab to view the DHCPLs.